Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience (Q35894865)
Jump to navigation
Jump to search
scientific article published in April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience |
scientific article published in April 2002 |
Statements
1 reference
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience (English)
1 reference
Henry S Friedman
1 reference
Sridharan Gururangan
1 reference
Allan H Friedman
1 reference
Roger E McLendon
1 reference
Christopher D Turner
1 reference
James Eastwood
1 reference
Krystal Bottom
1 reference
Melody Watral
1 reference
Rodney Beason
1 reference
Sandra Tourt-Uhlig
1 reference
Langdon L Miller
1 reference
Identifiers
1 reference